← Eichor
Study identifier: NCT07149649 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)

Condition: Metastatic NSCLC - Non-Small Cell Lung Cancer  ·  Sponsor: Swiss Cancer Institute

PhasePhase 2/Phase 3
Planned participants230
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study investigates whether adding magnesium to the standard chemo-immunotherapy for advanced non-small cell lung cancer (NSCLC) can improve treatment outcomes. Magnesium is important for immune function, and low levels during chemotherapy are common. Participants are randomly assigned to receive either magnesium or a placebo, both as infusions and tablets. Neither the participants nor the doctors know who receives which treatment. The study compares the two groups to see if magnesium helps and how well it is tolerated.

This description comes directly from the study's public registry record.

Talk to the study team

Gisela Müller, PhD  ·  +41 31 389 91 91  ·  trials@swisscancerinstitute.ch

Always discuss trial participation with your own doctor first.

Locations (11)

Tumorzentrum Aarau - Hirslanden TZAAarau, SwitzerlandRecruiting
Kantonsspital AarauAarau, SwitzerlandRecruiting
Kantonsspital BadenBaden, SwitzerlandRecruiting
St. ClaraspitalBasel, SwitzerlandRecruiting
Universitätsspital BaselBasel, SwitzerlandRecruiting
Kantonsspital GraubuendenChur, SwitzerlandRecruiting
Luzerner KantonsspitalLucerne, SwitzerlandRecruiting
Kantonsspital OltenOlten, SwitzerlandRecruiting
Kantonsspital - St. GallenSankt Gallen, SwitzerlandRecruiting
Spital STS AGThun, SwitzerlandRecruiting
Kantonsspital WinterthurWinterthur, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07149649